U.S. Pharmacist



Fake Avastin Circulating in U.S.

By Staff


US Pharm. 2012;37(3):11.

Silver Spring, MD—A counterfeit version of the cancer drug Avastin has been sold to at least 19 oncologists and oncology clinics in this country. Tests of the fake product revealed that the active ingredient in Avastin was missing. The FDA, which is still analyzing the contents of the fake vials, has not received any reports of patient harm. The counterfeit Avastin, which was sold to sites in California, Texas, and Chicago, was imported from Britain and distributed by Volunteer Distribution, a Gainesboro, Tennessee–based wholesaler. The FDA was notified about the fake product by British regulators in December. This and other instances of fake drugs (Lipitor, Viagra, and Alli) in the U.S. may indicate that the drug-counterfeiting trade is on the increase here.

To comment on this article, contact rdavidson@uspharmacist.com.


U.S. Pharmacist is a monthly journal dedicated to providing the nation's pharmacists with up-to-date, authoritative, peer-reviewed clinical articles relevant to contemporary pharmacy practice in a variety of settings, including community pharmacy, hospitals, managed care systems, ambulatory care clinics, home care organizations, long-term care facilities, industry and academia. The publication is also useful to pharmacy technicians, students, other health professionals and individuals interested in health management. Pharmacists licensed in the U.S. can earn Continuing Education credits through Postgraduate Healthcare Education, LLC, accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

Copyright © 2000 - 2016 Jobson Medical Information LLC unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is prohibited.